Global /China /Healthcare /Drug Manufacturers - General /000788

PKU HealthCare Corp.,Ltd.

000788

• SHE: 000788 • Delayed

6.12CNY -2.1%

0.9057 USD

As of 18 June 2026, PKU HealthCare Corp.,Ltd. has a market cap of $551.17M USD, ranking #14524 globally and #4503 in China. It ranks #1286 in the Healthcare sector, and #478 in the Drug Manufacturers - General industry.

Global Rank

14524

Country Rank

4503

Sector Rank

1286

Industry Rank

478

Key Stats

Market Cap

$551.17MUSD

3.72B CNY

Enterprise Value

$421.36MUSD

2.85B CNY

Revenue (TTM)

$176.85MUSD

1.2B CNY

EBITDA (TTM)

$24.4MUSD

164.89M CNY

Net Income (TTM)

$9.51MUSD

64.24M CNY

EBITDA Margin

14%

Profit Margin

5.4%

PE Ratio

58.0

PS Ratio

3.1

PB Ratio

2.5

EV/EBITDA

17.2

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Ping Dong Yuan open_in_new

Employees

772

Founded

1965

Website

pku-hc.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.1%	-3%	3.6%	-3.3%	-0.8%	0.2%	9.3%	-13%	-15%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	000788 北大医药股份有限公司 Class A ISIN: CNE0000008M0 Shares Out.: Shares Outstanding: 595.987M¹ Shares Float: 568.371M² TV: TradingView: SZSE: 000788 SA: Stock Analysis: SHE: 000788 YF: Yahoo Finance: 000788.SZ GF: Google Finance: SHE: 000788 BA: Barron's: 000788 MS: Morningstar: XSHE: 000788	6.12 CNY	TV: TradingView: SZSE: 000788 SA: Stock Analysis: SHE: 000788 YF: Yahoo Finance: 000788.SZ GF: Google Finance: SHE: 000788 BA: Barron's: 000788 MS: Morningstar: XSHE: 000788

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About PKU HealthCare Corp.,Ltd.

PKU HealthCare Corp.,Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers products in various categories, including cardiovascular and cerebrovascular, antimicrobial, antipyretic and analgesic, digestive system, oncology, anti-allergic, blood sugar and immunity regulation, mental disorder, and blood volume expansion. It also provides tumor screening, health management, diagnosis, and treatment services. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. PKU HealthCare Corp.,Ltd. was founded in 1965 and is headquartered in Chongqing, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.99B 364.89B CNY 10K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.77B 336.36B CNY 9K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 5K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 3K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.56B 111.89B CNY 3K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 3K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 138K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 99K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 65K%	97.4	United States
Roche Holding AG SIX: RO	$323.08B 256.25B CHF 59K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.5B 215.59B GBP 52K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.99B 218.9B CHF 50K%	20.5	Switzerland

chevron_leftBack